Skip to main content

JDRF has now rebranded to Breakthrough T1D.
Our name has changed, our mission has not.

Making treatments available

Our international research programme means that life-changing treatments and developments for type 1 diabetes are in clinical trials around the world.

Hybrid closed loop technology

As new treatments become available, we want to make sure that they are delivered through the NHS to people with type 1 diabetes as quickly as possible.

Working with the NHS

To achieve this we provide evidence and patient input to the National Institute for Health and Care Excellence (NICE) and the Scottish Intercollegiate Guidelines Network (SIGN). These are the two organisations that evaluate which medicines should be prescribed and paid for by the NHS, and provide guidelines to doctors about best treatment practices.

Representing people with type 1

As well as providing input for NICE and SIGN treatment reviews ourselves, we work with industry and researchers to ensure that they are producing appropriate evidence for these two bodies.

We also make sure that patients’ views are represented by asking people with type 1 diabetes to take part in reviews, and we help to keep people with type 1 up to date about the best and latest treatment options so that they can discuss them with their healthcare team.

Type 1 technology

We are a member of the Medical Technology Group (MTG), a coalition of patient groups, research charities and medical device manufacturers working to improve access to cost-effective medical technologies for everyone who needs them.

In 2018 we merged with diabetes technology advocacy group INPUT to address some of the problems which delay adoption of new treatments and technology through the NHS. We also work closely with partners like Diabetes UK to advocate for faster access to technology.

Treatment advocacy news

Read more
Grid of unbranded vials of insulin with purple tops
Research
27 June 2025

Update on NovoRapid PumpCart supply for YpsoPump users

We’re aware of growing concern around insulin supply in the UK, and we want to reassure our community that this is not a general insulin shortage. There is no need to change the type of insulin you use.

Read more
Two young people sat in a park, with type 1 diabetes continuous glucose monitor visible on their arms
Breakthrough T1D
20 June 2025

Warning issued for Dexcom G6 users as Android 16 update causes compatibility issues

If you use the Dexcom G6 app on your Android smartphone, the newest Android 16 operating system may disrupt how the app functions.

Read more
Two older men at home reading type 1 diabetes information booklets.
Research
17 June 2025

Healthcare systems unprepared for rising number of older adults with T1D

We're calling for urgent reform as new report reveals older people with T1D are systematically failed by health and social care services.

Read more
MEPs and Breakthrough T1D staff posing for a photograph at the European Parliament
Breakthrough T1D
6 June 2025

Breakthrough T1D helps organise event at the European Parliament

Breakthrough T1D has helped organise an event hosted by Tomislav Sokol titled ‘Accelerating Breakthroughs to Address Unmet Needs in Type 1 Diabetes.’